Cytotrait raised £3,000,000 in a seed round (lead investor not specified in the article). Prior to this round the company received £498,000 from ARIA to develop hybrid seed production in wheat. Investors named in the article include Northern Gritstone, Future Planet Capital, Parkwalk Advisors / Northern Universities Ventures Fund and UK Innovation & Science Seed Fund.
About Cytotrait
Spinout from The University of Manchester developing crop engineering technology for precise gene editing in plant organelles (chloroplasts and mitochondria) via its proprietary MOSS platform to enable improved crop traits, resilience and sustainable agriculture.
Manchester, United Kingdom
Read Company Profile
Source: https://techfundingnews.com/manchester-spinout-cytotrait-bags-3m-to-build-more-resilient-crops/
Frequently Asked Questions
What type of funding round did Cytotrait raise?
Cytotrait raised a seed round.
How much did Cytotrait raise in its seed?
Cytotrait raised $3,000,000 GBP in its seed.
When did Cytotrait raise its seed?
Cytotrait raised its seed on 2026-03-09.
Who invested in Cytotrait's seed?
The investors in Cytotrait's seed are: Northern Gritstone, Future Planet Capital, Parkwalk Advisors / Northern Universities Ventures Fund, UK Innovation & Science Seed Fund (UKI2S), ARIA (Advanced Research and Invention Agency).
What type of investment was Cytotrait's seed?
Cytotrait's seed was a equity investment.
How will Cytotrait use the funds from its seed?
Cytotrait plans to use the funds for: Expand research programmes into wheat, maize, potato and canola, Accelerate development and validation of MOSS technology and early data, Expand pipeline and translate laboratory breakthroughs into field-ready innovations, Target European and North American markets.